Volume 20, Number 7—July 2014
Lessons for Control of Heroin-Associated Anthrax in Europe from 2009–2010 Outbreak Case Studies, London, UK
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; (4) view/print certificate.
Release date: June 11, 2014; Expiration date: June 11, 2015
Upon completion of this activity, participants will be able to:
1. Describe clinical manifestations of heroin-associated anthrax in the 2009–2010 outbreak in the United Kingdom, based on a study report
2. Discuss the epidemiology of heroin-associated anthrax in the 2009–2010 UK outbreak
3. Identify lessons learned from the 2009–2010 UK outbreak of heroin-associated anthrax
Jean Michaels Jones, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Jean Michaels Jones has disclosed no relevant financial relationships.
Laurie Barclay, MD, freelance writer and reviewer, Medscape, LLC. Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.
Disclosures: Aula Abbara, MBBS, BSc, DTM&H; Graham P. Taylor, MB, DSc; Marianne Nolan, MB BCh, BAO, FRCPath; Maribel Manikon, MBBS, MRCP; and Alison Holmes, MD, MPH, FRCP, have disclosed no relevant financial relationships. Timothy J.G. Brooks, MD, has disclosed no relevant financial relationships; Dr Brooks does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States. Hugo Donaldson, MB, BCh, has disclosed the following financial relationships: served as a speaker or a member of a speakers bureau for Astellas.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: June 12, 2014
- Page last updated: June 12, 2014
- Page last reviewed: June 12, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)